Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pediatric
25%
Antibiotics
23%
COVID-19
22%
Urinary Tract Infection
22%
Children's Hospital
19%
Virus
19%
Uropathogenic Escherichia Coli
18%
Antimicrobial Stewardship Program
18%
United States
17%
Escherichia Coli
15%
Methicillin-resistant Staphylococcus Aureus
14%
Antibiotic Use
14%
Cytomegalovirus
14%
Soft Tissue Infection
13%
Skin Tissue
13%
Klebsiella Pneumoniae (K. pneumoniae)
13%
St. Louis
13%
Pediatric Patients
12%
Staphylococcus
12%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
12%
Missouri
12%
Antimicrobial Stewardship
12%
Antimicrobial
11%
Methicillin-resistant S. Aureus
10%
Polymerase Chain Reaction
10%
L-plastin
10%
Risk Factors
9%
Hospitalized children
9%
Respiratory Syncytial Virus
9%
Infections in children
9%
Stewardship
9%
Pediatric Infectious Diseases
9%
95% Confidence Interval
8%
Bladder
8%
Cytomegalovirus Infection
8%
Infectious Diseases
8%
Viral
8%
Neonatal Intensive Care Unit
7%
Clinical Outcomes
7%
Infection Prevention
7%
Lung Transplantation
7%
Epidemiology
7%
Murine Model
7%
Ganciclovir
7%
Antibiotic Prescribing
6%
Neonate
6%
Pyelonephritis
6%
Pediatric Antimicrobial Stewardship
6%
Macrophages
6%
Autophagy
6%
Bloodstream Infection
6%
Recurrent Urinary Tract Infections (rUTI)
5%
Decolonization
5%
Clostridium Difficile Infection
5%
Odds Ratio
5%
Hospitalization
5%
CA-MRSA
5%
Antibiotic Duration
5%
Bacterial Infection
5%
Quantitative PCR
5%
Antimicrobial Use
5%
Gut Microbiota
5%
Influenza
5%
Urinary Tract
5%
Vaccination
5%
Astrovirus
5%
Renal Transplant Recipients
5%
Pediatric Intensive Care Unit
5%
Viremia
5%
High Risk
5%
Cystic Fibrosis
5%
Actin-binding Proteins
5%
Antibiotic Resistance
5%
Virulence
5%
Fever
5%
Immunology and Microbiology
Infection
100%
Infectious Disease
99%
Urinary Tract
25%
Infectious Agent
19%
Virus
19%
Uropathogenic Escherichia Coli
18%
Staphylococcus Aureus
17%
Escherichia coli
15%
Cytomegalovirus
13%
Antimicrobial Agent
12%
Klebsiella pneumoniae
9%
Bacterium
9%
Prevalence
9%
Microbiome
9%
Metagenomics
8%
Human Respiratory Syncytial Virus
8%
Methicillin-Resistant Staphylococcus Aureus
8%
Lung Transplantation
7%
Viremia
7%
Polymerase Chain Reaction
7%
T Cell
7%
Antigen
7%
Virus Infection
7%
Macrophage
7%
In Vitro
7%
Autophagy
6%
Actin
6%
Pilus
6%
Susceptibility
6%
Soft Tissue
6%
Astroviridae
6%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Antibiotic Resistance
5%
Neutrophil
5%
Gut Microbiome
5%
Leukocyte
5%
Titer
5%
Lung
5%
Neisseria meningitidis
5%
Medicine and Dentistry
Pediatrics
35%
Infection
26%
Antimicrobial Agent
21%
Antibiotics
14%
Diseases
13%
Antimicrobial Stewardship
13%
COVID-19
12%
Staphylococcus Aureus
11%
Methicillin Resistant Staphylococcus Aureus
10%
Infectious Disease
9%
Virus
9%
Pediatric Infection
8%
Polymerase Chain Reaction
8%
Soft Tissue Infection
7%
Odds Ratio
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Pediatrics Patient
6%
Clinician
6%
Antiinfective Agent
6%
Antibiotic Therapy
6%
Meticillin
6%
Cytomegalovirus
6%
Influenza
5%
Prevalence
5%
Health Care Cost
5%
Pathogen
5%
Oral
5%